Sm. Marshall et al., EFFECTS OF HEPARIN ON RENAL MORPHOLOGY AND ALBUMINURIA IN EXPERIMENTAL DIABETES, American journal of physiology: endocrinology and metabolism, 34(2), 1996, pp. 326-332
Female nondiabetic and streptozotocin diabetic Wistar rats received 20
0 units heparin two times daily by subcutaneous injection for 6 mo. Me
sangial volume fraction was reduced in heparin-treated control (CH) co
mpared with untreated control (C) animals (CH 0.18 +/- 0.02 vs. C 0.24
+/- 0.02, P < 0.05), but other histological parameters were similar.
In the heparin-treated diabetic (DH) group, wet kidney weight was incr
eased compared with the untreated diabetic (D) group (DH 1,156 +/- 39
vs. D 1,050 +/- 30 mg, P < 0.05), as were absolute, but not fractional
, glomerular volume (P < 0.05) and capillary volume (P < 0.05). Baseme
nt membrane thickness (DH 193 +/- 3 vs. D 231 +/- 9 nm, P < 0.01) and
mesangial/glomerular volume fraction (P < 0.001) were decreased. Urina
ry albumin excretion was increased in the heparin-treated control anim
als compared with control animals [CH 980 (range 150-4,446) vs. C 221
(range 86-654) mu g/24 h, P < 0.001] and in the heparin-treated diabet
ic animals compared with the diabetic animals [DH 12,785 (range 4,495-
29,520) vs. D 899 (range 450-1,335) mu g/24 h, P < 0.001]. Thus the po
ssibly deleterious increases in glomerular capillary volume and albumi
n excretion may negate the beneficial effects of heparin on mesangial
and basement membrane structures.